[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_10422 

# __Reduced performance due to virus transport medium__

## Articles mentionning the risk

* [Zhao_supporting_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_499.md)

## Mitigations of this risk

* [Avoid diluting samples below the assayâ€™s limit of detection](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_12332.md)

## Name of the risk

Potential for false-negative results in low positive samples

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Testing laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1155.md)

## Stakeholders who can mitigate this risk

* [Diagnostic laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8518.md)

## Technologies linked to the risk

* [Direct swab testing without elution in virus transport medium](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12279.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Poor access to diagnostics and treatment](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_41.md)

